Acerus Pharmaceuticals Corporation will announce financial results for the three and twelve month periods ending December 31, 2019 on Wednesday, March 4, 2020 before the market opens.
TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB :ASPCF) will announce financial results for the three and twelve month periods ending December 31, 2019 on Wednesday, March 4, 2020 before the market opens.
About Acerus
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.
Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200226005662/en/
Contacts
Acerus Pharmaceuticals Corporation
Robert Motz
Chief Financial Officer
rmotz@aceruspharma.com
(905) 817-8288
Source: Acerus Pharmaceuticals Corporation
View this news release online at:
http://www.businesswire.com/news/home/20200226005662/en
